Cargando…

Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis

AIM: Our goal was to improve treatment outcomes for visceral leishmaniasis by designing nanocarriers that improve drug biodistribution and half-life. Thus, long-acting mannose-anchored thiolated chitosan amphotericin B nanocarrier complexes (MTC AmB) were developed and characterized. MATERIALS &...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahnaz, Gul, Edagwa, Benson J, McMillan, JoEllyn, Akhtar, Sohail, Raza, Abida, Qureshi, Naveeda A, Yasinzai, Masoom, Gendelman, Howard E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144491/ https://www.ncbi.nlm.nih.gov/pubmed/27879160 http://dx.doi.org/10.2217/nnm-2016-0325

Ejemplares similares

Formulation and characterisation of a self‐nanoemulsifying drug delivery system of amphotericin B for the treatment of leishmaniasis
por: Khan, Momin, et al.
Publicado: (2019)

Dolutegravir Inhibition of Matrix Metalloproteinases Affects Mouse Neurodevelopment
por: Bade, Aditya N., et al.
Publicado: (2021)

ProTide generated long-acting abacavir nanoformulations
por: Lin, Zhiyi, et al.
Publicado: (2018)

Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes
por: Edagwa, Benson J., et al.
Publicado: (2014)

Creation of a Long-Acting Nanoformulated 2′,3′-Dideoxy-3′-Thiacytidine
por: Guo, Dongwei, et al.
Publicado: (2017)

Annihilation of Leishmania by daylight responsive ZnO nanoparticles: a temporal relationship of reactive oxygen species-induced lipid and protein oxidation
por: Nadhman, Akhtar, et al.
Publicado: (2016)

Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy
por: Li, Tianyuzi, et al.
Publicado: (2015)

Nanoformulated Antiretroviral Therapy Attenuates Brain Metabolic Oxidative Stress
por: Montenegro-Burke, J. Rafael, et al.
Publicado: (2018)

Pharmacokinetics of a Long-Acting Nanoformulated Dolutegravir Prodrug in Rhesus Macaques
por: McMillan, JoEllyn, et al.
Publicado: (2017)

Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages
por: Araínga, Mariluz, et al.
Publicado: (2015)

Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy
por: Martinez-Skinner, Andrea L., et al.
Publicado: (2015)

Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals
por: Zhou, Tian, et al.
Publicado: (2018)

Methods Development for Blood Borne Macrophage Carriage of Nanoformulated Antiretroviral Drugs
por: Balkundi, Shantanu, et al.
Publicado: (2010)

Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles
por: Cobb, Denise A., et al.
Publicado: (2021)

Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation
por: Ibrahim, Ibrahim M, et al.
Publicado: (2019)

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
por: Boska, Michael, et al.
Publicado: (2010)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

Ocular Leishmaniasis Treated by Intralesional Amphotericin B
por: Nikandish, Malihe, et al.
Publicado: (2016)

ZnO-NPs embedded biodegradable thiolated bandage for postoperative surgical site infection: In vitro and in vivo evaluation
por: Arshad, Rabia, et al.
Publicado: (2019)

EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment
por: Gu, Chao-Jiang, et al.
Publicado: (2018)

Creation of a long-acting nanoformulated dolutegravir
por: Sillman, Brady, et al.
Publicado: (2018)

Liposomal amphotericin B as a treatment for human leishmaniasis
por: Balasegaram, Manica, et al.
Publicado: (2012)

Efficacy of Intralesional Amphotericin B for the Treatment of Cutaneous Leishmaniasis
por: Goyonlo, Vahid Mashayekhi, et al.
Publicado: (2014)

Amphotericin B Formulations and Other Drugs for Visceral Leishmaniasis
por: Berman, Jonathan
Publicado: (2015)

Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
por: Ubals, Maria, et al.
Publicado: (2021)

Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study
por: Hasnain, Md Golam, et al.
Publicado: (2018)

Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
por: Gautam, Nagsen, et al.
Publicado: (2021)

Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
por: Morizot, Gloria, et al.
Publicado: (2016)

Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC)
por: Tuon, Felipe Francisco, et al.
Publicado: (2018)

Disseminated tegumentary leishmaniasis refractory to liposomal amphotericin B treatment
por: Borges, Ana Flávia, et al.
Publicado: (2021)

Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
por: Zhou, Tian, et al.
Publicado: (2017)

Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection
por: Coya, Juan Manuel, et al.
Publicado: (2019)

Proceedings of the Sixth International Conference on Management Science and Engineering Management : Focused on Electrical and Information Technology
por: Xu, Jiuping, et al.
Publicado: (2013)

Auricular leishmaniasis in a child successfully treated with intralesional amphotericin B
por: Diociaiuti, Andrea, et al.
Publicado: (2022)

Failure of an Innovative Low-Cost, Noninvasive Thermotherapy Device for Treating Cutaneous Leishmaniasis Caused by Leishmania tropica in Pakistan
por: Kämink, Suzette, et al.
Publicado: (2019)

Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues
por: Kevadiya, Bhavesh D., et al.
Publicado: (2020)

Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea
por: Guery, Romain, et al.
Publicado: (2017)

Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India
por: Fakiola, Michaela, et al.
Publicado: (2019)

Activity of Amphotericin B-Loaded Chitosan Nanoparticles against Experimental Cutaneous Leishmaniasis
por: Riezk, Alaa, et al.
Publicado: (2020)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_55hi24b3b5urkoprb2fv7pkg4c